A detailed history of Lakeside Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Lakeside Advisors, Inc. holds 17,176 shares of ABBV stock, worth $3.46 Million. This represents 2.17% of its overall portfolio holdings.

Number of Shares
17,176
Previous 17,601 2.41%
Holding current value
$3.46 Million
Previous $3.02 Million 12.36%
% of portfolio
2.17%
Previous 2.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$163.84 - $199.33 $69,632 - $84,715
-425 Reduced 2.41%
17,176 $3.39 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $61,916 - $72,304
-400 Reduced 2.22%
17,601 $3.02 Million
Q1 2024

Apr 29, 2024

BUY
$159.82 - $182.1 $5,593 - $6,373
35 Added 0.19%
18,001 $3.28 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $35,088 - $39,517
-255 Reduced 1.4%
17,966 $2.78 Million
Q3 2023

Oct 19, 2023

SELL
$133.59 - $154.65 $53,436 - $61,860
-400 Reduced 2.15%
18,221 $2.72 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $13,251 - $16,490
-100 Reduced 0.53%
18,621 $2.51 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $7,230 - $8,327
-50 Reduced 0.27%
18,721 $2.98 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $48,408 - $58,054
-350 Reduced 1.83%
18,771 $3.04 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $26,842 - $30,786
-200 Reduced 1.04%
19,121 $2.57 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $27,524 - $34,992
-200 Reduced 1.02%
19,321 $2.96 Million
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $26,395 - $32,750
-200 Reduced 1.01%
19,521 $3.17 Million
Q4 2021

Mar 08, 2022

BUY
$107.43 - $135.93 $2.12 Million - $2.68 Million
19,721 New
19,721 $2.67 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lakeside Advisors, Inc. Portfolio

Follow Lakeside Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakeside Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lakeside Advisors, Inc. with notifications on news.